QVT Financial Portfolio holdings
QVT Financial manages private funds and began as a trading group inside an investment bank; since 2018 it has mainly managed the money of its own principals and a handful of private investors. That change gave it a steadier source of money and room to hold more concentrated positions for longer. Its strategies include long and short stock trades, convertible securities, credit trades and hedges against sharp market drops. Its principal owners include chief executive Daniel Gold, Nicholas Brumm, Arthur Chu and Tracy Fu.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$66.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$9.22M |
| 3 |
Nexstar Media Group
NXST
|
+$8.17M |
| 4 |
RAAQ
Real Asset Acquisition Corp
RAAQ
|
+$6.94M |
| 5 |
Radcom
RDCM
|
+$6.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roivant Sciences
ROIV
|
+$42.5M |
| 2 |
Amicus Therapeutics
FOLD
|
+$10.1M |
| 3 |
Birkenstock
BIRK
|
+$9.8M |
| 4 |
Goldman Sachs
GS
|
+$7.82M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$7.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.38% |
| 2 | Miscellaneous | 16.75% |
| 3 | Technology | 9.72% |
| 4 | Financials | 7.99% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Broadcom
AVGO
$1.74T
| $6.3M | 0.37% |
16,675
-1,054
| -6% | -$423K |
2025 Q4
2 quarters
|
|
|
27
Radcom
RDCM
$184M
| $6.28M | 0.37% |
+445,265
| New | +$6.25M |
2026 Q2
0 quarters
|
|
28
Janus Henderson AAA CLO ETF
JAAA
$32.6B
| $5.99M | 0.35% |
118,582
| – | – |
2025 Q2
4 quarters
|
|
29
Oracle Corp Preferred Stock Series D
ORCL.PRD
| $5.61M | 0.33% |
125,000
-50,000
| -29% | -$2.69M |
2026 Q1
1 quarter
|
|
30
Biohaven
BHVN
$2.22B
| $5.27M | 0.31% |
354,206
+184,200
| +108% | +$1.98M |
2023 Q3
11 quarters
|
|
31
Summit Therapeutics
SMMT
$12.8B
| $5.25M | 0.31% |
360,524
| – | – |
2024 Q2
8 quarters
|
|
32
argenx
ARGX
$61.5B
| $4.84M | 0.28% |
5,218
| – | – |
2017 Q2
36 quarters
|
|
33
PUT
Rigetti Computing
RGTI
$3.75B
| $4.83M | 0.28% |
250,000
+70,000
| +39% | +$1.35M |
2025 Q4
2 quarters
|
|
34
Blackstone Secured Lending
BXSL
$5.55B
| $4.44M | 0.26% |
187,226
-62,408
| -25% | -$1.49M |
2025 Q4
2 quarters
|
|
35
Advanced Micro Devices
AMD
$963B
| $4.06M | 0.24% |
6,988
-545
| -7% | -$223K |
2025 Q4
2 quarters
|
|
36
iShares Biotechnology ETF
IBB
$11.2B
| $3.52M | 0.21% |
+18,497
| New | +$3.18M |
2026 Q2
0 quarters
|
|
37
Comtech Telecommunications
CMTL
$36.8M
| $3.34M | 0.2% |
1,676,031
-18,436
| -1% | -$70.9K |
2024 Q3
7 quarters
|
|
38
Synopsys
SNPS
$89.7B
| $2.91M | 0.17% |
6,522
-1,029
| -14% | -$484K |
2024 Q4
6 quarters
|
|
39
Iovance Biotherapeutics
IOVA
$3.6B
| $2.82M | 0.17% |
678,564
| – | – |
2015 Q1
45 quarters
|
|
40
DoorDash
DASH
$77.2B
| $2.67M | 0.16% |
14,469
-1,640
| -10% | -$271K |
2025 Q2
4 quarters
|
|
41
PUT
IonQ
IONQ
$15.1B
| $2.66M | 0.16% |
50,000
-320,000
| -86% | -$16.2M |
2025 Q1
5 quarters
|
|
42
PUT
D-Wave Quantum Inc
QBTS
$3.93B
| $2.4M | 0.14% |
100,000
-260,000
| -72% | -$5.7M |
2025 Q3
3 quarters
|
|
43
Mayfair Gold Corp
MINE
$159M
| $2.13M | 0.12% |
909,999
| – | – |
2026 Q1
1 quarter
|
|
44
TSMC
TSM
$2.13T
| $1.92M | 0.11% |
4,018
+378
| +10% | +$153K |
2026 Q1
1 quarter
|
|
45
Applied Materials
AMAT
$314B
| $1.84M | 0.11% |
2,550
-736
| -22% | -$340K |
2026 Q1
1 quarter
|
|
46
Corning
GLW
$104B
| $1.64M | 0.1% |
6,410
+2,246
| +54% | +$409K |
2026 Q1
1 quarter
|
|
47
CALL
Sandisk
SNDK
$135B
| $1.59M | 0.09% |
+700
| New | +$999K |
2026 Q2
0 quarters
|
|
48
MACOM Technology Solutions
MTSI
$19.1B
| $1.47M | 0.09% |
3,876
-764
| -16% | -$253K |
2025 Q3
3 quarters
|
|
49
MKS Inc
MKSI
$15.2B
| $1.19M | 0.07% |
+2,686
| New | +$841K |
2026 Q2
0 quarters
|
|
50
Palo Alto Networks
PANW
$263B
| $1.17M | 0.07% |
3,441
-2,921
| -46% | -$669K |
2025 Q4
2 quarters
|
|
Similar funds
QVT Financial's Q2 2026 Portfolio in Review
As of Q2 2026, QVT Financial held 94 positions worth $1.7B, up 25% from $1.37B the previous quarter. Its ten largest holdings account for 77% of the portfolio.
QVT Financial's Q2 2026 filing shows 17 new, 14 increased, 26 reduced and 13 closed positions. Its largest new stake was Radcom: 445,265 shares worth $6.28M. The largest sale was Roivant Sciences, an estimated $42.5M.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Miscellaneous and Technology.
- QVT Financial's largest Q2 2026 buy was Radcom: 445,265 shares worth $6.28M.
- QVT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $66.1M increase.
- QVT Financial's biggest Q2 2026 reduction was Roivant Sciences, cutting an estimated $42.5M.
- QVT Financial fully exited Amicus Therapeutics in Q2 2026, selling an estimated $10.1M.
- QVT Financial's ten largest holdings make up 77% of its $1.7B portfolio in Q2 2026.
- QVT Financial opened 17 new positions and closed 13 in Q2 2026.
- QVT Financial's portfolio value rose 25% quarter-over-quarter to $1.7B.
Based on QVT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.